Medication adherence in patients with type 2 diabetes mellitus treated at primary health clinics in Malaysia

Purpose Diabetes mellitus is a growing global health problem that affects patients of all ages. Even though diabetes mellitus is recognized as a major chronic illness, adherence to antidiabetic medicines has often been found to be unsatisfactory. This study was conducted to assess adherence to medications and to identify factors that are associated with nonadherence in type 2 diabetes mellitus (T2DM) patients at Primary Health Clinics of the Ministry of Health in Malaysia. Materials and methods The cross-sectional survey was carried out among T2DM patients to assess adherence to medication in primary health clinics. Adherence was measured by using the Medication Compliance Questionnaire that consists of a total of seven questions. Other data, such as patient demographics, treatment, outcome, and comorbidities were also collected from patient medical records. Results A total of 557 patients were recruited in the study. Approximately 53% of patients in the study population were nonadherent. Logistic regression analysis was performed to predict the factors associated with nonadherence. Variables associated with nonadherence were age, odds ratio 0.967 (95% confidence interval [CI]: 0.948–0.986); medication knowledge, odds ratio 0.965 (95% CI: 0.946–0.984); and comorbidities, odds ratio 1.781 (95% CI: 1.064–2.981). Conclusion Adherence to medication in T2DM patients in the primary health clinics was found to be poor. This is a cause of concern, because nonadherence could lead to a worsening of disease. Improving medication knowledge by paying particular attention to different age groups and patients with comorbidities could help improve adherence.

[1]  Heather M. Shearer,et al.  Adherence to Health Care , 2001 .

[2]  T. Paraidathathu,et al.  Medication adherence among hypertensive patients of primary health clinics in Malaysia , 2012, Patient preference and adherence.

[3]  Korey K. Hood,et al.  Changes in Treatment Adherence and Glycemic Control During the Transition to Adolescence in Type 1 Diabetes , 2012, Diabetes Care.

[4]  S. Leichter Making Outpatient Care of Diabetes More Efficient: Analyzing Noncompliance , 2005 .

[5]  Perry R. Hinton SPSS Explained , 2004 .

[6]  M. Ibrahim,et al.  Medication noncompliance--a thriving problem. , 1999, The Medical journal of Malaysia.

[7]  Adrian R Levy,et al.  Self-Reported Morisky Score for Identifying Nonadherence with Cardiovascular Medications , 2004, The Annals of pharmacotherapy.

[8]  A. Sönnerborg,et al.  Adherence to treatment in Swedish HIV‐infected patients , 2006, Journal of clinical pharmacy and therapeutics.

[9]  R. Misra,et al.  Ethnic and gender differences in psychosocial factors, glycemic control, and quality of life among adult type 2 diabetic patients. , 2009, Journal of diabetes and its complications.

[10]  D. Huet,et al.  Therapeutic compliance: a prospective analysis of various factors involved in the adherence rate in type 2 diabetes. , 2006, Diabetes & metabolism.

[11]  D. Sackett,et al.  Can Simple Clinical Measurements Detect Patient Noncompliance? , 1980, Hypertension.

[12]  R. Zelkó,et al.  Self-reported medication and lifestyle adherence in Hungarian patients with Type 2 diabetes , 2007, Pharmacy World & Science.

[13]  J. Shaw,et al.  The prevention of type 2 diabetes--lifestyle change or pharmacotherapy? A challenge for the 21st century. , 2003, Diabetes research and clinical practice.

[14]  A. Lippman Adherence to medication. , 2005, The New England journal of medicine.

[15]  R. Passier,et al.  Measurement of patient compliance. , 1998, Pharmacy World and Science.

[16]  J. Cramer A systematic review of adherence with medications for diabetes. , 2004, Diabetes care.

[17]  D. Bartels Adherence to oral therapy for type 2 diabetes: opportunities for enhancing glycemic control. , 2004, Journal of the American Academy of Nurse Practitioners.

[18]  P. Muntner,et al.  Reliability of a Medication Adherence Measure in an Outpatient Setting , 2005, The American journal of the medical sciences.

[19]  R. Holman,et al.  United Kingdom Prospective Diabetes Study 17: A 9-Year Update of a Randomized, Controlled Trial on the Effect of Improved Metabolic Control on Complications in Non-Insulin-dependent Diabetes Mellitus , 1996, Annals of Internal Medicine.

[20]  L. Green,et al.  Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence , 1986, Medical care.

[21]  R. Rubin,et al.  Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus. , 2005, The American journal of medicine.